Combined Vitrectomy and Triamcinolone in Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)

Helse Stavanger HF

Status and phase: Terminated; Phase 3

Conditions: Macular Edema; Branch Retinal Vein Occlusion

Treatments: Procedure: Vitrectomy and 20 mg triamcinolone; Procedure: Grid Laser

Study type: Interventional

Funder types: Other

Identifiers

NCT00642226

3.2006.1159(REK)

14836 (Other Identifier)

3.2006.1159 (Other Identifier)

Details and patient eligibility

About

The purpose of this study is to determine whether pars plana vitrectomy in combination with triamcinolone acetate is effective in the treatment of macular edema due to branch retinal vein occlusion.

Enrollment: 34 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Macular edema secondary to BRVO
• Best Corrected Visual Acuity of ≤ 20/40 on ETDRS chart
• Duration no shorter than 3 months
• Duration no longer than 12 months

Exclusion criteria

• Proliferations in study eye
• Blod in vitreous cavity
• Previous fundus laser treatment
• BRVO with over 180˚ of ischemia on FA
• Age under 18
• Other eye condition which contribute to relevant loss of visual acuity

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

34 participants in 2 patient groups

1

Active Comparator group

Description:

Grid Laser

Treatment:

Procedure: Grid Laser

2

Experimental group

Description:

Vitrectomy in combination with 20 mg triamcinolone

Treatment:

Procedure: Vitrectomy and 20 mg triamcinolone